HCPCS Code Descriptor:
Injection, leuprolide acetate (for depot suspension), per 3.75 mg
00074-2282-03, 00074-3641-03, 00074-3663-03, 00074-3779-03, 00074-9694-03, 00074-2440-03, 00074-2108-03
LEUPROLIDE DEPOT 505(b)(2) Pathway
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
LUPRON DEPOT is a Growth Disorder drug manufactured by Abbvie and administered via the Intramuscular route of administration. The J Code: J1950 is aligned to the drug LUPRON DEPOT.